ROLE OF GUANINE-NUCLEOTIDE-BINDING PROTEINS, G(I-ALPHA-3) AND G(S-ALPHA), IN DOPAMINE AND THYROTROPIN-RELEASING-HORMONE SIGNAL-TRANSDUCTION- EVIDENCE FOR COMPETITION AND COMMONALITY
Rd. Kineman et al., ROLE OF GUANINE-NUCLEOTIDE-BINDING PROTEINS, G(I-ALPHA-3) AND G(S-ALPHA), IN DOPAMINE AND THYROTROPIN-RELEASING-HORMONE SIGNAL-TRANSDUCTION- EVIDENCE FOR COMPETITION AND COMMONALITY, Journal of Endocrinology, 148(3), 1996, pp. 447-455
It is clear that dopamine (DA) at high concentrations (>100 nmol/l) in
hibits the release of prolactin (PRL). Paradoxically, this monoamine a
t low concentrations (<10 nmol/l) has also been shown to augment PRL s
ecretion. One possible explanation for these divergent effects is that
DA binds receptors capable of interacting with multiple G protein sub
types that recruit opposing intracellular signaling pathways within la
ctotropes. To identify G proteins which couple DA receptor activation
to PRL secretion, we have selectively immunoneutralized the activity o
f G(i alpha 3) and G(s alpha) in primary cultures of rat pituitaries a
nd subsequently tested the ability of these cultures to respond to hig
h and low dose DA. Specifically, permeabilized pituitary cell cultures
from random-cycling female rats were treated with control immunoglobu
lins (IgGs; 50 mu g/ml) purified from preimmune serum (PII) or IgGs di
rected against the C-terminal portion of G(i alpha 3) or G(s alpha). A
fter immunoneutralization of these G proteins, cells were challenged w
ith 10 or 1000 nmol DA/l and the relative amount of PRL released was a
ssessed by reverse hemolytic plaque assay. Results were expressed as %
of basal values and compared. Under control conditions (PII), 1000 nm
ol DA/l inhibited (61.4 +/- 7.6% of basal values; mean +/- S.E.M.) whi
le 10 nmol DA/l augmented (120.0 +/- 7.0%) PRL release in five separat
e experiments. Treatment of cells with anti-G(i alpha 3) attenuated th
e inhibitory effect of high dose DA (87.3 +/- 14.5%). However, elimina
tion of G(i alpha 3) activity did not significantly alter the PRL stim
ulatory effect of 10 nmol DA/l (121.0 +/- 5.2%). Interestingly, immuno
neutralization of G(s alpha) resulted in a reciprocal shift in the act
ivity of the lower dose of DA from stimulatory to inhibitory (69.7 +/-
7.3%) while combined treatment of anti-G(i alpha 3) and anti-G(s alph
a) abrogated the responsiveness of pituitary cell cultures to either D
A treatment (1000 nmol/l, 70.7 +/- 12.5% and 10 nmol/l, 87.5 +/- 21.4%
). These data reveal that ligand-activated DA receptors can interact w
ith both G(i alpha 3) and G(s alpha). Elimination of the stimulatory c
omponent (G(s alpha) favors the DA receptor activation of the inhibito
ry pathway (G(s alpha)) suggesting a competition between negative and
positive intracellular signaling mechanisms in normal lactotropes. In
addition to DA treatment, we also challenged permeabilized pituitary c
ells with 100 nmol thyrotropin-releasing hormone (TRH)/l as a positive
control for secretory integrity. As anticipated, TRH stimulated PRL r
elease to 188.0 +/- 31.0% of basal values under control conditions. Un
expectedly, immunoneutralization of G(s alpha) completely blocked the
ability of TRH to induce PRL release (101.8 +/- 12.0%). This neutraliz
ing effect was specific to G(s alpha) in that blockade of G(i alpha 3)
activity had no significant effect on TRH-stimulated PRL release (166
.2 +/- 13.1%). These data are the first to support a direct role of G(
s alpha) in TRH signal transduction within PRL-secreting cells.